Mark Hancock, co-founder and executive vice chairman of $PACS Group, Inc., sold 138,069 shares of $PACS common stock on June 25, 2026, at an average price of approximately $40.33 per share, generating proceeds of roughly $5.57 million. The transaction was conducted on the open market and disclosed via Form 4 filing on June 26, one day after the trade.
He did not stop there. On June 26, the same day the first filing landed, Hancock executed two additional open-market sales totaling 61,931 shares: 61,731 shares at an average of approximately $40.50 and a separate 200-share block at $41.01, bringing in a further $2.51 million. Across both trading days, his combined proceeds from the three transactions reached approximately $8.08 million.
Despite the volume of shares moved, Hancock retained a substantial position in the company. Following the June 25 sale alone, his reported ownership stood at 54,164,528 shares. The sold shares represent a small fraction of his overall stake in the health care company.
Hancock is the only $PACS insider in the database with recorded sales this month, though he is not the only executive to have sold shares over recent months. Chief Legal Officer and Secretary John Todd Mitchell recorded four open-market sales in May 2026, spread across May 15 and May 18, totaling approximately $3.02 million at prices ranging from roughly $37.01 to $38.74 per share. Chief Operating Officer Joshua Jergensen also sold 36,335 shares on March 13, 2026, at an average of about $34.28 per share for proceeds of approximately $1.25 million.
Mitchell had previously sold 159,556 shares on November 24, 2025, at around $29.89 per share, a transaction valued near $4.77 million, making him a consistent seller across multiple disclosure windows. That same day in November, Director Evelyn S. Dilsaver moved in the opposite direction, purchasing 16,724 shares at approximately $29.90 per share for roughly $500,000.
The stretch of executive activity at $PACS Group runs from late 2025 through late June 2026, with open-market sales recorded across at least three different insiders at prices ranging from the high $20s to the low $40s. Hancock's two-day total represents the largest single-insider dollar amount in that period. His retained holding of more than 54 million shares leaves him among the company's most significant individual stakeholders on record.